NCT00025389View on ClinicalTrials.gov

Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2005

Study Completion Date

August 31, 2007

Conditions
Lung Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

carboplatin

DRUG

paclitaxel

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (2)

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

60637-1470

University of Chicago Cancer Research Center, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Chicago

OTHER

NCT00025389 - Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter